Cancer Genomic Workshop

This intensive Cancer Genomics Workshop offers a deep dive into the molecular landscape of tumors using cutting-edge bioinformatics and AI-driven diagnostic frameworks. As we move into 2026, the integration of Machine Learning (ML) and Multi-omics is essential for identifying actionable mutations and predicting patient responses to immunotherapy. Participants will explore the transition from traditional pathology to genomic profiling, learning to navigate complex datasets from Liquid Biopsy and Single-Cell Analytics. The course bridges the gap between laboratory discovery and clinical application, emphasizing Somatic vs. Germline variation and the ethical use of AI in healthcare. By the end of this program, you will be equipped to interpret high-throughput data and contribute to Genomic Tumor Boards, ensuring patient-centric breakthroughs in treatment.